Toppoint Holdings Inc. Reports Third Quarter and First Nine-Month Results Reflecting Growth in Emerging Commodity Segments Despite Global Tariff Pressures

Toppoint Holdings Inc. (TOPP) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 ea030148101ex99-1.htm PRESS RELEASE DATED AUGUST 12, 2026 Exhibit 99.1 FOR IMMEDIATE RELEASE August 12, 2026 Toppoint Holdings Inc. Reports Second Quarter 2026 Financial Results Revenue Up 17% Year-Over-Year to $4.6 Million; Net Loss Narrows 80%; Gross Margin Returns to

Nvidia revised its funding guarantee for a proposed OpenAI data center in Ohio, expected to initially back less than $120 billion versus $250 billion previously discussed, the Wall Street Journal reported. The chipmaker would provide a backstop only for the first phase. The change followed investor concerns about Nvidia’s financing risk exposure.

AbbVie (ABBV) says its neuroscience portfolio is expected to generate about $12.7 billion in revenue in 2026, up by $100 million after strong first-half performance. In Q2, neuroscience revenue rose 20.3% to $3.23 billion, led by Vraylar ($1.07B), therapeutic Botox ($1.04B), Ubrelvy and Qulipta ($742M), and Vyalev ($256M).

Oppenheimer upgraded Intuitive Surgical (ISRG) from “Perform” to “Outperform” and set a $500 price target, implying about 24.6% upside, citing robotic surgery growth and AI plans. The article notes Q2 revenue of $2.89B (vs $2.82B expected), EPS $2.80, da Vinci and Ion procedure growth, and ISRG guidance for da Vinci growth of 13.5% to 15.5%.

Lockheed Martin said the Missile Defense Agency awarded it a seven-year, $35 billion contract in June to quadruple THAAD interceptor production to about 400 per year. The ramp is supported by more than $9 billion in munitions investments through 2030, including a new Troy, Alabama production center. The company also cited concurrent plans to expand PAC-3 MSE and PrSM output.

The article argues Fermi (FRMI) is being misread after its 10 Aug 2026 Project Matador deal with TensorWave. It cites a 15-year, about $6.5bn binding lease for 222 MW phase 1, plus expansion rights, and notes FRMI closed at $6.40 and has an $17.50 consensus analyst target. It compares the setup to SanDisk’s contract-driven re-rating.